20260922_INAF_Pengumuman RUPS_32150305_lamp1.pdf

                                 ANNOUNCEMENT
                 EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
                           PT INDOFARMA (PERSERO) TBK

The Board of Directors of PT Indofarma (Persero) Tbk ("Company") hereby announces that
the Company's 2026 Extraordinary General Meeting of Shareholders ("EGMS") will be held
on Thursday, October 29, 2026.

In accordance with the Financial Services Authority Regulation Number 15/POJK.04/2020
concerning the Plan and Organization of General Meetings of Shareholders of Public
Companies ("POJK Number 15 of 2020") juncto the Financial Services Authority Regulation
Number 16/POJK.04/2020 concerning the Electronic Organization of General Meetings of
Shareholders of Public Companies ("POJK Number 16 of 2020"), notice of the EGMS will be
given through the eASY.KSEI platform, which can be accessed at https://akses.ksei.co.id, the
website of the e-RUPS service provider, the website of the Indonesia Stock Exchange, and the
Company's website (www.indofarma.id), on October 07, 2026.

Shareholders entitled to attend or be represented at the EGMS are those Shareholders whose
names are recorded in the Company's Register of Shareholders and/or the owners of the
Company's share balances in the securities sub-accounts within the Collective Custody of PT
Kustodian Sentral Efek Indonesia ("KSEI") as at the close of trading on the Indonesia Stock
Exchange on October 06, 2026.

In accordance with Article 16 of POJK Number 15 of 2020, 1 (one) or more Shareholders
representing 1/20 (one-twentieth) or more of the total number of shares issued by the
Company with valid voting rights, and the holder of the Series A Dwiwarna Share, are entitled
to propose agenda items for the EGMS. Such proposal must be submitted in writing to the
Company's Board of Directors no later than 7 (seven) days prior to the date of the EGMS
Notice, i.e. September 30, 2026, accompanied by the reasons for and supporting materials of
the proposed EGMS agenda item(s), and provided that such proposal does not conflict with
the prevailing laws and regulations.


                               Jakarta, September 22, 2026
                                PT Indofarma (Persero) Tbk
                                     Board of Directors